6.78
-0.17(-2.45%)
Currency In USD
| Previous Close | 6.95 |
| Open | 6.95 |
| Day High | 7.03 |
| Day Low | 6.53 |
| 52-Week High | 18.55 |
| 52-Week Low | 4.3 |
| Volume | 233,743 |
| Average Volume | 240,911 |
| Market Cap | 177.31M |
| PE | -3.29 |
| EPS | -2.06 |
| Moving Average 50 Days | 7.63 |
| Moving Average 200 Days | 9.99 |
| Change | -0.17 |
If you invested $1000 in CVRx, Inc. (CVRX) since IPO date, it would be worth $242.14 as of September 18, 2025 at a share price of $6.78. Whereas If you bought $1000 worth of CVRx, Inc. (CVRX) shares 3 years ago, it would be worth $819.83 as of September 18, 2025 at a share price of $6.78.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire Inc.
Jul 29, 2025 12:30 PM GMT
MINNEAPOLIS, July 29, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascu
CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025
GlobeNewswire Inc.
Jul 21, 2025 8:30 PM GMT
MINNEAPOLIS, July 21, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascu
CVRx Announces Positive News on Outpatient Payment for Barostim
GlobeNewswire Inc.
Jul 16, 2025 11:30 AM GMT
MINNEAPOLIS, July 16, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services (CMS) has proposed to keep the Barostim implant proced